You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 5, May 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Diabetic Retinopathy
 •Alert me on articles by topic

Understanding the Value of Diabetic Retinopathy Screening

Donald S. Fong, MD, MPH; Justin Gottlieb, MD; Frederick L. Ferris III, MD; Ronald Klein, MD, MPH

Arch Ophthalmol. 2001;119:758-760.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Regular dilated eye examinations are an effective approach to detecting and treating vision-threatening diabetic retinopathy.1 They can help prevent blindness, and they are cost-effective.2-3 Guidelines for systematic screening have been developed because patients with retinopathy are often asymptomatic, and photocoagulation treatment is more effective at reducing visual loss when applied at specific, frequently asymptomatic, stages of retinopathy.4-5 However, despite the recommendations for regular screening and the availability of effective treatment, many patients at risk of visual loss due to severe retinopathy are not receiving dilated eye examinations and needed photocoagulation treatments.6-7

Guidelines for the frequency of dilated eye examinations have been largely based on the severity of the retinopathy.8-9 For patients with moderate to severe nonproliferative diabetic retinopathy, frequent eye examinations are often necessary to determine when to initiate treatment. However, for patients . . . [Full Text of this Article]

From the Department of Ophthalmology, Southern California Permanente Medical Group, Baldwin Park (Dr Fong); Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison (Drs Gottlieb and Klein); and the Division of Biometry and Epidemiology, National Eye Institute, National Institutes of Health, Bethesda, Md (Dr Ferris).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease
Murgatroyd et al.
Br. J. Ophthalmol. 2004;88:920-924.
ABSTRACT | FULL TEXT  

Preventing Visual Loss From Chronic Eye Disease in Primary Care: Scientific Review
Rowe et al.
JAMA 2004;291:1487-1495.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.